Evidence map›Paper›PMID 42667389›Full record

ArticleRheumatology international2026

Mental- and physical-health comorbidity are strongly associated in idiopathic inflammatory myopathies: a multinational cross-sectional e-survey.

Samuel Katsuyuki Shinjo, Lekshmi Minikumari Rahulan, Meera Shah, Anchit Chauhan, Suhana Hussain, Paula Jordan, Meghna Lama, Oladipo Kunle Afolayan, Vincenzo Venerito, Tamar B Rubinstein and 11 more

Abstract readMulticenter Study
In one paragraph

Article in Rheumatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Samuel Katsuyuki ShinjoDivision of Rheumatology, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, SP, Brazil.ORCID http://orcid.org/0000-0002-3682-4517
Lekshmi Minikumari RahulanDepartment of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.ORCID http://orcid.org/0009-0003-5921-3684
Meera ShahDepartment of Rheumatology, Topiwala National Medical College and B.Y.L Nair Hospital, Mumbai, India.ORCID http://orcid.org/0009-0005-3308-7231
Anchit ChauhanMaulana Azad Medical College, New Delhi, India.ORCID http://orcid.org/0009-0000-3834-144X
Suhana HussainMahatma Gandhi Medical College and Hospital, Jaipur, India.ORCID http://orcid.org/0009-0007-3072-0163
Paula JordanHonorary General Secretary, Myositis, UK.
Meghna LamaThe University of Texas Health Science Center at Houston School of Public Health: Houston, Texas, USA.ORCID http://orcid.org/0009-0009-6177-5145
Oladipo Kunle AfolayanThe University of Texas Health Science Center at Houston School of Public Health: Houston, Texas, USA.ORCID http://orcid.org/0000-0002-4621-3648
Vincenzo VeneritoRheumatology Unit, Department of Precision and Regenerative Medicine-Ionian Area, University of Bari "Aldo Moro", Bari, Italy.ORCID http://orcid.org/0000-0002-2573-5930
Tamar B RubinsteinDivision of Rheumatology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, USA.ORCID http://orcid.org/0000-0001-8170-9377
Ioannis ParodisDivision of Rheumatology, Department of Medicine Solna, Center for Molecular Medicine (CMM), Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-4875-5395
Elena NikiphorouCentre for Rheumatic Diseases, King's College London, London, UK.ORCID http://orcid.org/0000-0001-6847-3726
Joanna MakowskaDepartment of Rheumatology, Medical University of Lodz, Zeromskiego 113, 90-549, Lodz, Poland.ORCID http://orcid.org/0000-0003-2036-375X
Aleksandra Opinc-RosiakDepartment of Rheumatology, Medical University of Lodz, Zeromskiego 113, 90-549, Lodz, Poland.ORCID http://orcid.org/0000-0002-7881-5731
Rada MiskovicClinic of Allergy and Immunology, Faculty of Medicine, University Clinical Centre of Serbia, University of Belgrade, Belgrade, Serbia.ORCID http://orcid.org/0000-0003-0982-2572
Marcin MilchertDepartment of Internal Medicine, Rheumatology, Diabetology, Geriatrics and Clinical Immunology of Pomeranian Medical University in Szczecin, Szczecinie, Poland.ORCID http://orcid.org/0000-0002-0943-8768
Dimitri Luz Felipe da SilvaUniversity Santo Amaro, Hospital Israelita Albert Einstein, São Paulo, Brazil.ORCID http://orcid.org/0000-0003-0869-9330
COVAD Study Group
Vahed MaroufyDepartment of Biostatistics and Data Science, School of Public Health, The University of Texas Health Center at Houston, Austin, TX, 77002, USA.ORCID http://orcid.org/0000-0002-6653-7586
Vikas Agarwal *Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.ORCID http://orcid.org/0000-0002-4508-1233
Latika GuptaDepartment of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK. drlatikagupta@gmail.com.ORCID http://orcid.org/0000-0003-2753-2990

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Comorbidities are associated with morbidity, function, and survival in idiopathic inflammatory myopathies (IIM), but subtype-specific patterns, mental-physical comorbidity relationships, and patient-reported outcomes remain incompletely characterized. We hypothesized that multimorbidity in IIM is heterogeneous, associated with demographic, clinical, and psychosocial factors, and linked to differences in physical function and fatigue. We studied 1028 adults with self-reported, specialist-confirmed IIM. Comorbidities were assessed using the Functional Comorbidity Index and categorized into basic, complex, mental-health, and autoimmune domains. Logistic regression identified factors associated with mental- and physical-health comorbidity; clustering defined comorbidity patterns. Participants were predominantly female (71.3%), median age 59.0 years. Overall, 46.7% had basic multimorbidity, 15.4% complex multimorbidity, 33.6% mental-health comorbidity, and 14.7% autoimmune multimorbidity. Interstitial lung disease was concentrated in anti-synthetase syndrome (50.7%) and polymyositis (42.6%), while hypertension (37.8%) and malignancy (35.0%) were concentrated in inclusion body myositis. Chronic pain/fatigue syndromes were associated with mental-health burden (63.2% vs. 27.5%, p < 0.001). Mental-health comorbidity was associated with younger age (OR 0.98/year), complex multimorbidity (OR 2.85), immunosuppressive therapy (OR 1.53), and lower family support (OR 0.94/unit). Physical-health comorbidity was independently associated with older age (OR 1.05/year), mental-health comorbidity (OR 3.96), and overlap myositis (OR 3.33). Clustering identified three multimorbidity profiles: low-burden (49.3%), cardiometabolic/malignancy-predominant with low mental-health burden (22.9%), and pain-fatigue/mental-health-predominant (27.7%), which differed significantly in physical function and fatigue. Multimorbidity in IIM is common, heterogeneous, and shows a strong concurrent relationship between mental- and physical-health comorbidity, supporting integrated mental-health screening and subtype-tailored surveillance.

Indexed as

Mental HealthMyositisAdultAgedComorbidityCross-Sectional StudiesFatigueFemaleHealth StatusHumansMaleMiddle AgedMultimorbidityCluster analysisInclusion bodyLogistic modelsMorbidityMultimorbidityMyositisPatient reported outcome measures

Identifiers

PMID42667389
PMCPMC13526107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.